Drugs for Rare and Infectious Diseases
FDA Drug Approvals for Rare Diseases and Infectious Diseases Generating Antibiotics Incentives Now Act GAIN Act (S.1734)
The GAIN ActĀ provides incentives to help bring new antibiotics and otherĀ antimicrobials to market.
A drug with particular promiseĀ can be designated as a Qualified Infectious Disease ProductĀ (QIDP) by authority of the GAIN Act.
In 2014, FDA/CDERĀ approved four new antibioticsā¦
View On WordPress



















